Saturday 17 October 2026
Export MASS’s income statement to Excel — free account
908 Devices Inc.
MASS Healthcare Medical Devices
In the quarter to June 2026, revenue grew 23.3%, EPS grew 13.5% and free cash flow grew 151.0%, each against the same quarter a year earlier.
11.33
0.56
−4.71%
Follow MASS
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 4 | 3 | 3 | 3 | 6 | — | — | — |
P/E ratio |
9.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z-Score |
1.10 | (1.43) | 5.06 | 2.68 | 9.81 | 5.21 | — | — | — |
P/S ratio |
3.35 | 1.57 | 6.37 | 4.93 | 17.14 | 14.70 | 8.30 | 8.30 | — |
Altman Z″-Score (non-manufacturers) |
1.84 | (1.50) | 5.37 | 6.38 | 9.03 | 7.89 | (4.58) | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 95.91 | 0.00 | 0.00 | — |
Beneish M-Score |
(2.52) | (2.67) | (2.59) | (1.94) | (1.52) | (2.73) | 1.04 | — | — |
P/Operating CF |
142.89 | (33.42) | (165.71) | (45.18) | (78.45) | 169.53 | 29.89 | 29.89 | — |
P/B ratio |
1.31 | 0.65 | 1.93 | 1.21 | 3.37 | 2.84 | 0.00 | 0.00 | — |
Price to Tangible BV |
1.76 | 0.99 | 2.17 | 1.34 | 3.37 | 2.84 | 0.00 | 0.00 | — |
EV/Sales |
1.62 | 0.45 | 3.78 | 1.24 | 12.20 | 9.33 | 8.38 | 8.38 | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
(3.84) | (0.71) | (7.57) | (2.78) | (17.70) | 60.75 | (26.87) | (26.87) | — |
EV/FCF |
(3.69) | (0.70) | (7.00) | (2.53) | (17.26) | 60.88 | (25.75) | (25.75) | — |
Quick Ratio |
3.65 | 3.09 | 6.86 | 10.32 | 16.21 | 15.33 | 3.80 | 2.82 | — |
Current Ratio |
4.24 | 4.10 | 7.71 | 11.22 | 17.05 | 15.78 | 4.72 | 3.61 | — |
Net Debt/EBITDA |
3.17 | 5.73 | 3.58 | 5.14 | 9.89 | 28.97 | 0.18 | (1.96) | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 6.18% | 5.75% | 8.29% | 42.08% | 64.63% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.08 | 0.07 | 0.11 | (0.25) | 6.16 | — |
Asset Turnover |
0.32 | 0.26 | 0.23 | 0.19 | 0.19 | 0.25 | 0.55 | 1.59 | — |
Operating CF/Net income |
(1.22) | 0.42 | 0.69 | 0.62 | 1.31 | (0.32) | 0.82 | 1.17 | — |
Capex/Depreciation |
(0.25) | (0.01) | (0.98) | (1.27) | (0.80) | (0.01) | (0.44) | 0.00 | — |
Interest Coverage |
— | — | (212.73) | (274.28) | (45.41) | (5.96) | (7.94) | (10.33) | — |
| 15.09% | (51.56%) | (20.44%) | (16.57%) | (12.54%) | (34.03%) | 23.79% | 13.43% | — | |
| 11.15% | (39.84%) | (16.34%) | (13.33%) | (10.08%) | (11.93%) | (41.22%) | (54.87%) | — | |
ROIC |
(80.18%) | (78.54%) | (134.91%) | (128.74%) | (249.38%) | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
16.99% | (90.82%) | (23.55%) | (16.82%) | (9.25%) | (8.02%) | (56.52%) | (33.89%) | — |
Average Days of Receivables |
73.57 | 67.67 | 65.32 | 78.16 | 141.61 | 92.63 | 103.15 | 104.86 | — |
Research and Development Expense of Revenue |
27.72% | 31.39% | 43.61% | 37.41% | 30.96% | 30.62% | 50.04% | 43.20% | — |
Selling, General and Administrative Expense of Revenue |
68.56% | 82.65% | 91.72% | 93.65% | 76.38% | 46.49% | 62.84% | 42.19% | — |
Intangible Assets out of Total Assets |
0.19 | 0.24 | 0.09 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
17.52% | 24.64% | 19.48% | 15.38% | 5.93% | 1.95% | 1.49% | 0.00% | — |
Graham Net Nets |
0.52 | 0.78 | 0.43 | 0.71 | 0.29 | 0.33 | 0.14 | 0.14 | — |
Graham Number |
7.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
10.67% | (95.45%) | (11.39%) | (14.58%) | (3.09%) | (3.51%) | (1.10%) | (1.10%) | — |
Free Cash Flow Yield |
(13.08%) | (41.15%) | (8.48%) | (9.94%) | (4.12%) | 1.04% | (3.92%) | (3.92%) | — |
Revenue per Share |
1.57 | 1.40 | 1.56 | 1.49 | 1.51 | 4.90 | 3.60 | 0.84 | — |
Operating CF per Share |
(0.66) | (0.89) | (0.78) | (0.66) | (1.04) | 0.75 | (2.21) | (0.34) | — |
Capex per Share |
(0.03) | (0.02) | (0.06) | (0.06) | (0.03) | 0.00 | (0.08) | 0.00 | — |
Free Cash Flow per Share |
(0.69) | (0.91) | (0.84) | (0.73) | (1.07) | 0.75 | (2.28) | (0.34) | — |
Cash per Share |
3.15 | 2.02 | 4.52 | 5.98 | 8.01 | 29.03 | 3.59 | 0.27 | — |
Shareholders Equity per Share |
4.00 | 3.36 | 5.13 | 6.05 | 7.68 | 25.35 | (12.66) | 0.11 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
4.00 | 3.36 | 5.13 | 6.05 | 7.68 | 25.35 | (12.66) | 0.11 | — |
Free Cash Flow |
(24.64) | (30.85) | (27.10) | (22.97) | (29.82) | 4.12 | (11.40) | (8.90) | — |
Working Capital |
110.50 | 77.91 | 151.24 | 196.40 | 238.06 | 160.13 | 22.53 | 12.44 | — |
Capital Expenditures |
(0.95) | (0.60) | (2.04) | (2.04) | (0.74) | (0.01) | (0.39) | (0.73) | — |
Net Current Asset Value |
98.19 | 58.17 | 136.30 | 163.64 | 206.59 | 131.18 | (72.25) | (7.63) | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.02 | 0.01 | 0.04 | 0.04 | 0.02 | 0.00 | 0.02 | 0.00 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.90 | 28.44 | 0.62 | 0.52 | 0.58 | 0.98 | 0.68 | 0.09 | — |
Cash ROIC |
(9.60%) | (16.81%) | (8.71%) | (5.83%) | (6.57%) | 1.32% | 38.75% | (31.87%) | — |
Accounts Receivable Turnover |
5.57 | 5.35 | 5.28 | 3.55 | 3.64 | 4.52 | 3.15 | 3.86 | — |
Accounts Payable Turnover |
18.80 | 18.17 | 19.25 | 15.05 | 15.98 | 15.14 | 16.09 | 15.81 | — |
Inventory Turnover |
2.33 | 1.80 | 1.81 | 2.04 | 3.04 | 2.44 | 2.24 | 2.21 | — |
Average Days of Payables |
20.84 | 21.48 | 17.45 | 24.48 | 26.38 | 30.61 | 21.43 | 24.37 | — |
Days of Inventory on Hand |
170.71 | 170.93 | 218.91 | 219.27 | 152.33 | 139.28 | 194.48 | 133.10 | — |
Average Receivables |
10.09 | 8.92 | 9.51 | 13.20 | 11.60 | 5.95 | 5.71 | 5.71 | — |
Average Payables |
1.48 | 1.28 | 1.29 | 1.38 | 1.19 | 0.79 | 0.61 | 0.61 | — |
Average Inventory |
11.94 | 12.91 | 13.73 | 10.22 | 6.24 | 4.90 | 4.38 | 4.38 | — |
Average Assets |
174.77 | 181.23 | 222.78 | 251.75 | 219.87 | 108.24 | 32.71 | 13.87 | — |
Average Common Equity |
129.15 | 140.04 | 178.05 | 202.60 | 176.82 | 37.94 | (56.67) | (56.67) | — |
Columns are period end dates